Aetna Sells Medicare Biz Amid Review Of $69B CVS Deal
Aetna will sell its stand-alone Medicare prescription drug plan business to WellCare, as it looks to secure approval from antitrust regulators for its anticipated $69 billion sale to CVS, according to...To view the full article, register now.
Already a subscriber? Click here to view full article